Rentschler Biotechnologie GmbH & Co. Announces Cooperation with Boehringer Ingelheim Corporation
5/21/2008 4:02:07 PM
LAUPHEIM, Germany, May 21, 2008 - Rentschler Biotechnologie and Boehringer Ingelheim, both leading companies in biopharmaceutical development and production, have signed a preferred partnership agreement. The cooperation will enable Rentschler Biotechnologie’s clients to gain access to Boehringer Ingelheim’s large-scale mammalian biopharmaceutical production facilities in Biberach, Germany and vice versa, Boehringer Ingelheim’s clients to use Rentschler’s facilities of process development and intermediate-scale clinical supply production.